X0202 4 2007-08-10 0 0000812796 DOR BIOPHARMA INC DORB 0001068029 SCHABER CHRISTOPHER J 1101 BRICKELL AVENUE SUITE 701-S MIAMI FL 33131 1 1 0 0 Chief Executive Officer Stock Options (right ot buy) 0.27 2007-08-10 4 A 0 500000 0 A 2007-08-10 2016-08-28 Common Stock 500000 500000 D Stock Options (Right to Buy) 0.47 2007-08-10 4 A 0 900000 0 A 2007-08-10 2017-08-09 Common Stock 900000 900000 D 500,000 stock options were granted on August 10, 2007 as a result of the amendment to the original 2,500,000 options granted on August 29, 2006. This amendment was required because under the 2005 Equity Incentive Plan only 2,000,000 stock options were authorized in a calendar year. This amendment was filed on August 14, 2007 as a Form 3/A (Amendment) of the originally filed Form 3 of September 1, 2006. These stock options will vest 33.3% initially and 8.325% of the remaining balance will vest quarterly over a three year period. The stock options were granted at an exercise price of $0.47 per share, which is a 68% premium to the Company?s common stock price of $0.28 on August 10, 2007. The stock options, which are for a term of 10 years from the date of grant and subject to earlier termination upon the occurrence of certain events related to termination of employment, vest at the rate of 25% immediately and 25% per year for 3 years. /s/ Christopher J. Schaber 2007-08-14